Company / Free Cash Flow
Charles River Laboratories Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$518.5M
FY2025
5-year range
$340.4M / $532.0M
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
#39 of 150
Health Care
What the data says
At $518M, Charles River Laboratories's free cash flow ranks #39 of 150 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from $236M in FY2019 to $532M in FY2023.
Based on SEC 10-K filings.
$518M in FY2025 with a 5-year CAGR of +11.5%.
Declined from $532M to $518M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +10.9%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
#39 of 150 in Health CareTop 26% of 150This company $518.5M Sector average $782.1M
▼
-33.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.5%, indicating consistent growth.
- In FY2025, free cash flow increased 3.4% year-over-year.
- Ranks #39 out of 150 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $518.5M | +3.4% |
| FY2024 | $501.6M | -5.7% |
| FY2023 | $532.0M | +40.0% |
| FY2022 | $380.0M | +11.6% |
| FY2021 | $340.4M | +13.1% |
| FY2020 | $301.1M | +27.8% |
| FY2019 | $235.6M | -21.7% |
| FY2018 | $301.1M | +27.8% |
| FY2017 | $235.6M | -9.9% |
| FY2016 | $261.6M | +54.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026